載入...
Spotlight on ixazomib: potential in the treatment of multiple myeloma
Despite the significant therapeutic advances achieved with proteasome inhibitors (PIs) such as bortezomib and carfilzomib in prolonging the survival of patients with multiple myeloma, the development of drug resistance, peripheral neuropathy, and pharmacokinetic limitations continue to pose major ch...
Na minha lista:
| 發表在: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4714737/ https://ncbi.nlm.nih.gov/pubmed/26811670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S93602 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|